Sales rise 20.97% to Rs 175.15 crore
Net profit of Windlas Biotech rose 11.68% to Rs 13.48 crore in the quarter ended June 2024 as against Rs 12.07 crore during the previous quarter ended June 2023. Sales rose 20.97% to Rs 175.15 crore in the quarter ended June 2024 as against Rs 144.79 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales175.15144.79 21 OPM %11.9211.84 -PBDT24.5219.53 26 PBT18.3116.34 12 NP13.4812.07 12Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
